Search results
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Finance· 9 hours agoAn attractive pipeline candidate is the key lure for these companies. Cost synergies in research and...
New portable fentanyl sensor is super sensitive
Futurity· 1 hour agoA new fentanyl sensor is six orders of magnitude more sensitive than any electrochemical sensor for the drug reported in the past five years. The...
Mixing medications can produce a dangerous cocktail
WJXT Jacksonville· 9 hours agoOne thing doctors have to consider when prescribing a new medication is whether it will interact with any drugs the patient is already taking. “If the...
Counterfeit Oxycontin pills almost always contain fentanyl
UPI· 4 hours agoLab tests of counterfeit oxycodone (Oxycontin) pills seized by police in Rhode Island in 2022 found...
7 Benefits of Metformin (Including Weight Loss)
MediaFeed via AOL· 4 days agoMetformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for diabetes, you probably already...
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker...
Zacks via Yahoo Finance· 1 day agoReports for AstraZeneca, Qualcomm and FedEx The Zacks Research Daily presents the best research...
Can Philadelphia Fix One of the Most Drug-Plagued Neighborhoods in the Country?
The New York Times via Yahoo News· 7 hours agoPHILADELPHIA — The vow was unequivocal: The city of Philadelphia was finally going to root out the ...
Austin opioid overdose outbreak: Nearly 80 overdoses since Monday
KTBC via Yahoo News· 5 days agoBoth suspects had a known history of dealing narcotics, according to police. One of the suspects was...
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 1 day agoACADIA will report on May 8. Stay on top of upcoming earnings announcements with the Zacks Earnings...
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
Motley Fool via Yahoo Finance· 5 days agoKarnauskas maintained her buy recommendation on the stock. In a new research note, Karnauskas waxed...